申请人:ONO Pharmaceutical Co., Ltd.
公开号:EP2740724A1
公开(公告)日:2014-06-11
The present invention provides a compound of which active form is represented by a formula (A). and which can be injected into a joint cavity which is an affected part of disorders and can be accumulated in the joint cavity to exert the pharmacological effect thereof in a sustained manner, for the purpose of ameliorating cartilage disorders without developing any side effect. A compound according to the present invention, which is represented by a formula (I):
(wherein all of symbols are as defined in the description), is a compound that can achieve the above-mentioned purpose. This compound does not exhibit any side effect on the cardiovascular system even when the compound is administered in an effective amount for exhibiting a cartilage regeneration activity, and is therefore extremely useful as a safe and effective preventive and/or therapeutic agent for cartilage disorders. Since a suspension produced using this compound can be injected without requiring the incision of the affected part, it can reduce the burden on patients, and is extremely useful as a medicinal agent.
本发明提供了一种化合物,其活性形式由式(A)表示,可注射到受疾病影响的关节腔内,并可在关节腔内蓄积,以持续发挥其药理作用,从而达到改善软骨疾病而不产生任何副作用的目的。根据本发明的一种化合物,由式(I)表示:
(其中所有符号如描述中所定义)表示的化合物,可以达到上述目的。该化合物即使以有效量施用也不会对心血管系统产生任何副作用,从而显示出软骨再生活性,因此作为一种安全有效的软骨疾病预防和/或治疗剂极为有用。由于使用该化合物生产的混悬液无需切开患病部位即可注射,因此可以减轻患者的负担,作为一种药物非常有用。